Dapsone 8.5% / Niacinamide 2% / Tretinoin 0.025%
Product Images NDC 72934-1065

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dapsone 8.5% / Niacinamide 2% / Tretinoin 0.025% (NDC 72934-1065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sincerus Florida Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

H (2 End)

The image shows a white cylindrical container with a label panel containing directions for use. The label includes storage instructions to keep at controlled room temperature (20-25°C) and notes that the product is for external use only. Contact information for Sincerus Florida LLC, located in Pompano Beach, FL, is provided with phone numbers and a URL for reporting adverse reactions to the FDA. There is also a QR code on the label.*

FDA Label Image

C (1065 2 Front)

Packaging label of DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% gel in a 30gm container. The label shows the product NDC 72934-1065-2 and indicates it is a compounded drug made in the USA. The labeler is Sincerus Florida LLC, whose logo appears on the bottle.*

FDA Label Image

J (1065 2 Middle)

Side view of a white cylindrical container label for DAPSONE 8.5% / NIACINAMIDE 2% / TRETINOIN 0.025% gel by Sincerus Florida LLC. The label lists active ingredients with concentrations and inactive ingredients, including propylene glycol USP and gel base. The label also shows prescription status and batch information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.